Reference : Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYS...
Scientific journals : Article
Life sciences : Genetics & genetic processes
Human health sciences : Neurology
Systems Biomedicine
http://hdl.handle.net/10993/52077
Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM study
English
Weiss, Daniel [> >]
Landoulsi, Zied mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core]
May, Patrick mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core]
Sharma, Manu [> >]
Schüpbach, Michael [> >]
You, Hana [> >]
Corvol, Jean Christophe [> >]
Paschen, Steffen [> >]
Helmers, Ann-Kristin [> >]
Barbe, Michael [> >]
Fink, Gereon [> >]
Kühn, Andrea A. [> >]
Courbon, Christine Brefel [> >]
Wojtecki, Lars [> >]
Damier, Philippe [> >]
Fraix, Valerie [> >]
Houeto, Jean-Luc [> >]
Regis, Jean [> >]
Sixel-Döring, Friederike [> >]
Pinsker, Marcus O. [> >]
Thobois, Stephane [> >]
Gharabaghi, Alireza [> >]
Stoker, Valerie [> >]
Timmermann, Lars [> >]
Schnitzler, Alfons [> >]
Krack, Paul [> >]
Vidailhet, Marie [> >]
Deuschl, Günther [> >]
Krüger, Rejko mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience]
7-Sep-2022
Parkinsonism and Related Disorders
Elsevier
Yes
International
1353-8020
Netherlands
[en] Parkinson's disease ; Deep brain stimulation ; Alpha-synuclein ; Genetic association
[en] Purpose
The decision for subthalamic deep brain stimulation (STN-DBS) in Parkinson's disease (PD) relies on clinical predictors. Whether genetic variables could predict favourable or unfavourable decisions is under investigation.
Objective
First, we aimed to reproduce the previous observation that SNCA rs356220 was associated with favourable STN-DBS motor response. In additional exploratory analyses, we studied if other PD risk and progression variants from the latest GWAS are associated with therapeutic outcome. Further, we evaluated the predictive value of polygenic risk scores.
Methods
We comprehensively genotyped patients from the EarlyStim cohort using NeuroChip, and assessed the clinico-genetic associations with longitudinal outcome parameters.
Results
The SNCA rs356220 variant did not predict UPDRS III outcomes. However, it was associated with quality of life improvement in secondary analyses. Several polymorphisms from previously identified GWAS hits predicted motor or quality of life outcomes in DBS patients. Polygenic risk scores did not predict any outcome parameter.
Conclusions
Our findings support the hypothesis that different common genetic markers are associated with favourable quality of life outcomes of STN-DBS in PD. These findings can be the basis for further validation in larger and independent cohorts.
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) ; Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group)
Researchers ; Professionals
http://hdl.handle.net/10993/52077
10.1016/J.PARKRELDIS.2022.08.025
https://linkinghub.elsevier.com/retrieve/pii/S1353802022002826

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Limited access
Weiss2022.ParkRelDis.pdfPublisher postprint1.15 MBRequest a copy

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.